ES2191299T3 - Metodo de titulacion de una composicion viral compleja. - Google Patents

Metodo de titulacion de una composicion viral compleja.

Info

Publication number
ES2191299T3
ES2191299T3 ES98917302T ES98917302T ES2191299T3 ES 2191299 T3 ES2191299 T3 ES 2191299T3 ES 98917302 T ES98917302 T ES 98917302T ES 98917302 T ES98917302 T ES 98917302T ES 2191299 T3 ES2191299 T3 ES 2191299T3
Authority
ES
Spain
Prior art keywords
species
type
viruses
title method
viral composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98917302T
Other languages
English (en)
Inventor
Catherine Gerdil
Jean-Francois Saluzzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Application granted granted Critical
Publication of ES2191299T3 publication Critical patent/ES2191299T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

La invención se refiere a un procedimiento para determinar, en una composición que contiene diferentes especies o tipos de virus vivos, la cantidad de virus de cada uno de los tipos o especies, que comprende las siguientes etapas: propagación de los virus de cada tipo o especie en células permisivas a los virus pero que no inducen interferencia viral, dosificación de cada tipo o especie de virus mediante un anticuerpo monoclonal específico.
ES98917302T 1997-04-04 1998-04-03 Metodo de titulacion de una composicion viral compleja. Expired - Lifetime ES2191299T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704371A FR2761698B1 (fr) 1997-04-04 1997-04-04 Methode de titrage d'une composition virale complexe

Publications (1)

Publication Number Publication Date
ES2191299T3 true ES2191299T3 (es) 2003-09-01

Family

ID=9505710

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98917302T Expired - Lifetime ES2191299T3 (es) 1997-04-04 1998-04-03 Metodo de titulacion de una composicion viral compleja.

Country Status (15)

Country Link
US (1) US6890711B1 (es)
EP (1) EP0974055B1 (es)
KR (1) KR100543344B1 (es)
CN (1) CN1130465C (es)
AT (1) ATE235685T1 (es)
AU (1) AU737465B2 (es)
BR (1) BR9808482A (es)
CA (1) CA2285647C (es)
DE (1) DE69812601T2 (es)
DK (1) DK0974055T3 (es)
ES (1) ES2191299T3 (es)
FR (1) FR2761698B1 (es)
NZ (1) NZ500005A (es)
PT (1) PT974055E (es)
WO (1) WO1998045709A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1159969A1 (fr) * 2000-05-30 2001-12-05 Aventis Pasteur Vaccine composition
US8589667B2 (en) 2010-04-19 2013-11-19 Apple Inc. Booting and configuring a subsystem securely from non-local storage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511702B1 (fr) * 1981-08-24 1985-09-13 Pasteur Institut Anticorps monoclonaux antipoliovirus pour l'identification du type et la differenciation intratypique de souches isolees de poliovirus, hybrides cellulaires pour leur fabrication et procede de diagnostic in vitro mettant en jeu des anticorps
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
FR2694022B1 (fr) * 1992-07-21 1994-09-30 Int Mycoplasma Procédé d'amplification des agents infectieux en diagnostic "in vitro" sur cultures cellulaires.
JPH06222062A (ja) * 1993-01-22 1994-08-12 Teijin Ltd ウイルス感染価および中和抗体価の測定法

Also Published As

Publication number Publication date
FR2761698A1 (fr) 1998-10-09
US6890711B1 (en) 2005-05-10
AU7055298A (en) 1998-10-30
DE69812601D1 (de) 2003-04-30
KR100543344B1 (ko) 2006-01-20
CN1259207A (zh) 2000-07-05
CN1130465C (zh) 2003-12-10
NZ500005A (en) 2001-07-27
KR20010006045A (ko) 2001-01-15
DK0974055T3 (da) 2003-07-21
BR9808482A (pt) 2001-07-31
DE69812601T2 (de) 2003-10-09
FR2761698B1 (fr) 1999-05-07
EP0974055B1 (fr) 2003-03-26
WO1998045709A1 (fr) 1998-10-15
ATE235685T1 (de) 2003-04-15
EP0974055A1 (fr) 2000-01-26
PT974055E (pt) 2003-08-29
AU737465B2 (en) 2001-08-23
CA2285647C (fr) 2008-11-18
CA2285647A1 (fr) 1998-10-15

Similar Documents

Publication Publication Date Title
DK0891420T4 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
DK61890A (da) Fremgangsmaade til bestemmelse af antigener ved hjaelp af to eller flere monoklonale antistoffer
EA200400510A1 (ru) Агенты, специфически связывающие ангиопоэтин-2
DK164687C (da) Fremgangsmaade til sterilisering af gasimpermeable overflader med chlordioxid
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
ATA155598A (de) Neue influenzavirus-impfstoffzusammensetzung
DK472784D0 (da) Heterogen immunanalyse for digoxin ved hjaelp af ouabain som adskillelsesmiddel
DK99682A (da) Immunoanalysemetoder under anvendelse af monoklonale antistoffer
DK164884C (da) Fremgangsmaade til fremstilling af mikrobielle proteiner, som er opnaaet ud fra chlamydia trachomatis, til immunobestemmelse
DK226782A (da) Svingningstypediskriminerende apparat, f.eks. til lasergyroskoper
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
ES2191299T3 (es) Metodo de titulacion de una composicion viral compleja.
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
DK0709455T3 (da) Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an
SE8300486D0 (sv) Rengoringskomposition
NO164806C (no) Gasslaser for eksitering ved kondensatorutladning.
ES2118129T3 (es) Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos.
NO851518L (no) Monoklonale antistoffer eller fragmenter derav, spesifikke for alfa2-plasmininhibitor
EP0556320A4 (en) Monoclonal antibodies to hepatitis c virus and method for using same
NO157598C (no) Gasslaser som eksiteres ved kondensatorutladning.
ES2167725T3 (es) Procedimiento para la coloracion de material organico de alto peso molecular, y pigmentos policiclicos.
ES2061655T3 (es) Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos.
ES2126598T3 (es) Anticuerpos monoclonales que se fijan sobre las proteinas ns5 supuestas del virus de la hepatitis c, y procedimientos de utilizacion de estos anticuerpos.
EA200100437A1 (ru) Глюкурониды прегнана